- Among 200 patients hospitalized with COVID-19 in Wuhan, China, factors that increased the risk for developing acute respiratory distress syndrome (ARDS) and for dying include older age, neutrophilia, and higher lactate dehydrogenase and D-dimer levels, according to a JAMA Internal Medicine study. Among patients with ARDS, methylprednisolone was associated with lower risk for death.
No comments:
Post a Comment